knowledge -WSS

knowledge

author：hotspot 2025-10-02 14:39:19 - browse：76

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Why rehabilitation engineers need to center patients in their research

hotspot

WSS

Dogs on Prozac: What pet anti

CMS got Medicare Advantage quality rating wrong, judge rules

'Little Tech' descents on D.C., wanting a say in how AI is regulated

UnitedHealth financials solid despite Change Healthcare cyberattack

ASCO Daily Recap: CAR

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

knowledge

knowledge

hotspot

Psychedelics group wrestles with new pharma identity

Stopping antidepressants leads to symptoms for 1 in 6 patients

After affirmative action ruling, medical educators look to 'holistic review'

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

ChatGPT in medicine: STAT answers readers' burning questions

Dogs on Prozac: What pet anti

New air purifier tech could be key to improving indoor air quality

Health care needs a new profession: neuroimaging counseling

Cancer drug shortages should be causing more outrage

Eli Lilly’s Zepbound improved liver scarring in mid

focus

Melinda French Gates resigns from Gates Foundation

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Take antibiotics after sex, CDC recommends for certain risk groups

Why rehabilitation engineers need to center patients in their research

Fight over Supreme Court dialysis ruling puts kidney patients at risk

CMS got Medicare Advantage quality rating wrong, judge rules

hotspot

knowledge

hotspot

entertainment